For the US cannabis industry in 2019, all eyes are on the adult-use Michigan cannabis market.

On November 6, 2018, Michigan became the latest US state to say yes to legal adult-use cannabis. The fact that Michigan is the first state in the American midwest to do so makes the decision a particularly big deal for the legal cannabis industry. The move opens a major US market consisting of approximately 10 million people, while also paving the way for other midwestern states to follow suit in the near future.

The Michigan cannabis market could provide cannabis companies with a valuable foothold in the midwest when it comes time for states like Illinois and Ohio to join the club. For forward-thinking cannabis companies with ambitions of expansion, Michigan just made itself one of the most important markets in the United States.

This INNspired Article is brought to you by:

Grown Rogue is a vertically integrated, seed-to-experience cannabis company based in Medford, Oregon with operations throughout the United States.Send me an Investor Kit

According to projections by Marijuana Business Daily, the Michigan cannabis market could reach as high as US$1.7 billion in annual revenue within the first few years after legalization, putting it among the largest cannabis markets in the country.

The legalization process so far

Prior to 2018, Michigan was already the home of a robust medical cannabis industry established after a 2008 ballot initiative. The medical industry was worth approximately US$837 million in 2018, according to the state’s House Fiscal Agency. For the 2018 midterm elections, cannabis was once again on the ballot. Proposal 1 was approved by 56 percent of Michigan voters, setting a mandate for the state to create a regulatory system for recreational cannabis production and retail.

That process is now well underway, but the exact details of the regulatory scheme are not something that lawmakers can hammer out in a single session. The complex set of rules and regulations will likely take at least two years, with Proposal 1’s terms barring the state from issuing recreational commercial licenses until December 6, 2019, at the earliest. At that point, businesses holding existing medical cannabis licenses will have the first opportunity to apply for recreational cannabis commercial licenses.

The Michigan cannabis market

Based on the US$1.7 million projection, Michigan could become the second largest US cannabis market after California, which was projected to hit US$2.5 billion in its first year. Michigan also has the benefit of learning from California’s mistakes. California’s infamous dual licensing system, which required cannabis companies to apply for licenses from both the state and local municipalities, has been recognized as a regulatory failure. Based on the ballot proposal, Michigan looks likely to avoid an overly restrictive system such as California’s.

There are still plenty of important regulatory details that are yet to be determined. However, the ballot proposal itself provides some key details regarding what the Michigan cannabis market could look like. Under these provisions, the state will not place a limit on the number of adult-use licenses, but municipalities will have the freedom to set their own limitations on the number of licenses within their jurisdiction. While only current medical license holders will be able to apply for recreational licenses for the first 24 months of licensing, the state can choose to offer licenses to companies in the interest of quashing the black market and improving legal supply. The state will also have special license classifications for local micro-businesses, which will be capped at 100 plants.

Despite the regulatory questions still to be answered, cannabis companies are seeing plenty of opportunity in Michigan. As has been the case any time a new state legalizes the recreational cannabis industry, the early days provide a valuable first-mover advantage to the companies that get in the door first, and this is especially significant in a market the size of Michigan. The state has also seen some of the highest rates of cannabis adoption in the US, with the country’s second highest number of registered medical users. The midwest also has a huge agricultural sector, meaning infrastructure and skilled growing labor will be plentiful and relatively inexpensive. As mentioned above, it’s important to note that Michigan is the first midwest state to legalize with others likely to follow as early as 2020. Companies capable of establishing themselves in Michigan could gain early brand recognition, an understanding of midwestern markets and a familiarity with midwestern growing conditions. This early experience could provide first movers with a competitive advantage as more of the midwest opens up.

Michigan cannabis companies

Cannabis companies are now vying to get into the Michigan market as early as possible. One of the companies positioning itself to be among the first recreational producers in the state is Grown Rogue (CSE:GRIN, OTC:GRUSF). Grown Rogue announced in February 2019 that it had signed a binding agreement to secure the right to Michigan cannabis licenses and assets, including two retail dispensaries and a proposed 19,000 square foot cultivation and processing facility. “Michigan’s strong adoption of cannabis coupled with our strategic partnership with established business and real estate leaders made the expansion cost-effective and practical,” said Grown Rogue CEO Obie Strickler regarding the move. The multi-state cannabis company already has operations in Oregon and California.

Grassroots Cannabis is another multi-state cannabis company with eyes on Michigan. Grassroots has been working in the medical cannabis markets of Illinois and Ohio and the company’s CEO told Forbes in November that Grassroots is now seeing legalization in Michigan as a ground floor opportunity to find early success in the state. Viola Extracts, which currently operates in several states, including Michigan’s medical market, already operates a 48,000 square foot production facility in Detroit. In response to legalization in Michigan, the company is planning to add additional cultivation space in the state as well as a number of retail locations.


While we are in the early days of the Michigan cannabis industry, opportunities for growth have begun to emerge. The state represents one of the largest legal cannabis markets to come online to date, providing a potential gateway to a key American region. Across the United States, the broader cannabis market has taken notice. Michigan is learning from the successes and failures of cannabis-friendly states like California, and has the opportunity to become an important part of the US cannabis conversation going forward.

This INNSpired article is sponsored by Grown Rogue (CSE:GRIN, OTC:GRUSF). This INNSpired article provides information which was sourced by the Investing News Network (INN) and approved by Grown Rogue in order to help investors learn more about the company. Grown Rogue is a client of INN. The company’s campaign fees pay for INN to create and update this INNSpired article.

This INNSpired article was written according to INN editorial standards to educate investors.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with Grown Rogue and seek advice from a qualified investment advisor.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less